We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05053854
Brief Title: PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)

First Submitted : September 2, 2021
First Submitted that Met QC Criteria : September 20, 2021
First Posted : September 23, 2021

Last Update Submitted that Met QC Criteria : August 21, 2022
Last Update Posted : August 24, 2022